Literature DB >> 35325324

Role of IGF-1R in epithelial-mesenchymal transdifferentiation of human peritoneal mesothelial cells.

Yangyang Xia1, Cheng Wan1, Qingyan Zhang1, Hengjin Wang1, Yuan Feng2, Chunming Jiang3.   

Abstract

BACKGROUND: Peritoneal fibrosis (PF) is caused by epithelial-mesenchymal transdifferentiation (EMT) in the peritoneum under high glucose (HG) conditions. The study aimed to explored the role of Insulin-like growth factor 1 receptor (IGF-1R) in the regulation of EMT in human peritoneal mesothelial cells (HPMCs).
METHODS: We used HG peritoneal dialysis fluid (PDF) to induce in vivo PF in mice, and treated HPMCs with HG in vitro to stimulate EMT.
RESULTS: In the mice, the higher the glucose concentration in the dialysate, the more obvious the peritoneal tissue thickening and the more that collagen was deposited. The in vitro study indicated that the expression of IGF-1R, α-SMA, vimentin was upregulated, while the expression of occludin, ZO-1, and E-cadherin was downregulated in HPMCs under HG and IGF-1R overexpression conditions. Conversely, the expression of IGF-1R, α-SMA, and vimentin was downregulated, while the expression of occludin, ZO-1, and E-cadherin was upregulated in IGF-1R-underexpressed HPMCs under HG conditions. The cell migration abilities were increased, while the cell adhesion abilities were reduced in HPMCs under HG and IGF-1R overexpression conditions. In contrast, cell migration abilities were reduced, while cell adhesion abilities were increased in IGF-1Runderexpressed HPMCs under HG conditions.
CONCLUSIONS: Targeting at IGF-1R may provide novel insights into the prevention and treatment of PF.
© 2022. The Author(s), under exclusive licence to The Japanese Society of Nephrology.

Entities:  

Keywords:  Epithelial–mesenchymal transdifferentiation; Insulin-like growth factor 1 receptor; Peritoneal dialysis fluid; Peritoneal fibrosis

Mesh:

Substances:

Year:  2022        PMID: 35325324     DOI: 10.1007/s10157-022-02209-w

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  3 in total

1.  Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum.

Authors:  Jing Liu; Chun-Ming Jiang; Yuan Feng; Wei Zhu; Bo Jin; Yang-Yang Xia; Qing-Yan Zhang; Peng-Fei Xu; Miao Zhang
Journal:  Am J Transl Res       Date:  2019-03-15       Impact factor: 4.060

2.  Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.

Authors:  Z Zheng; R Ye; X Yu; J Bergström; B Lindholm
Journal:  Adv Perit Dial       Date:  2001

3.  IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1/STAT3 signaling pathway.

Authors:  Chao Su; Wenchang Wang; Cunchuan Wang
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.